Skip to main content
logo
InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8821
-0.0406 (-4.40%)
At close: Jan 30, 2026, 4:00 PM EST
0.9199
+0.0378 (4.29%)
After-hours: Jan 30, 2026, 7:45 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Novel Therapeutic Products
179.33K
Novel Therapeutic Products Growth
162.93%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
179.33K
United States Growth
162.93%